Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome

<p>Abstract</p> <p>Tocilizumab (TCZ) is the first FDA- approved treatment for systemic juvenile idiopathic arthritis (sJIA). We report 3 cases of cytopenias in children with sJIA treated with TCZ. Two of the children who developed significant cytopenias shortly after initiation of...

Full description

Saved in:
Bibliographic Details
Main Authors: Kessler Elizabeth A (Author), Vora Sheetal S (Author), Verbsky James W (Author)
Format: Book
Published: BMC, 2012-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5e42ebc3b3d64b5897e37dba377ed30b
042 |a dc 
100 1 0 |a Kessler Elizabeth A  |e author 
700 1 0 |a Vora Sheetal S  |e author 
700 1 0 |a Verbsky James W  |e author 
245 0 0 |a Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome 
260 |b BMC,   |c 2012-08-01T00:00:00Z. 
500 |a 10.1186/1546-0096-10-30 
500 |a 1546-0096 
520 |a <p>Abstract</p> <p>Tocilizumab (TCZ) is the first FDA- approved treatment for systemic juvenile idiopathic arthritis (sJIA). We report 3 cases of cytopenias in children with sJIA treated with TCZ. Two of the children who developed significant cytopenias shortly after initiation of TCZ had a history of macrophage activation syndrome. We raise the possibility that patients with a tendency towards MAS have an increased risk of developing cytopenias when treated with tocilizumab.</p> 
546 |a EN 
690 |a Juvenile idiopathic arthritis 
690 |a Macrophage activation syndrome 
690 |a Tocilizumab 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Diseases of the musculoskeletal system 
690 |a RC925-935 
655 7 |a article  |2 local 
786 0 |n Pediatric Rheumatology Online Journal, Vol 10, Iss 1, p 30 (2012) 
787 0 |n http://www.ped-rheum.com/content/10/1/30 
787 0 |n https://doaj.org/toc/1546-0096 
856 4 1 |u https://doaj.org/article/5e42ebc3b3d64b5897e37dba377ed30b  |z Connect to this object online.